Results 231 to 240 of about 8,592 (243)

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

Molecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder, Klaas de Lint, Hồ Mỹ Phúc Võ, Mariana M. Góis, Rosalie A. Kampen, Marta San Martin Alonso, Ilse Nootenboom, Veronica Garzero, Tiemen J. Wendel, Rob M. F. Wolthuis, Sylvie M. Noordermeer   +10 more
wiley   +1 more source

Predictive Factors of Malignancy in Cervical Paragangliomas: A Retrospective Study. [PDF]

Head Neck
Haw G, Fieux M, Flaus A, Lasolle H, Abeillon J, Decaussin-Petrucci M, Pavie D, Verillaud B, Herman P, Feugier P, Ameur F, Philouze P, Borson-Chazot F, Ceruse P.   +13 more
europepmc   +1 more source

[Amyloid light-chain (AL) amyloidosis and follicular lymphoma: a case report]. [PDF]

Pan Afr Med J
Benmoussa A, Maatoui-Belabbes H, Allali R, Regragui M, Qachouh M, Cherkaoui S, Lamchahab M, Rachid M, Madani A, Khoubila N.   +9 more
europepmc   +1 more source

Maladie de Castleman multicentrique idiopathique de sous-type TAFRO chez un homme de 22 ans. [PDF]

CMAJ
Rowe S, Collins BW, Pirzada A, Manning N, Chen LYC.   +4 more
europepmc   +1 more source

Olfactory Sequelae of Nasal Surgeries: A Systematic Review with Meta-Analysis. [PDF]

J Otolaryngol Head Neck Surg
Favreau A, Favier V, Carsuzaa F, Besser G, Giroudon C, Legré M, Tringali S, Benzerdjeb N, Nourredine M, Fieux M.   +9 more
europepmc   +1 more source

Electrochemical characterization of C. pasteurianum hydrogenase II and four site- directed variants: catalysis and inhibition

Malagnini M, Fasano A, Bailly A, Hardt L, Wenig T, Webb S, Milton R, Fourmond V, Leger C.   +8 more
europepmc   +1 more source

Correction to “Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors”

Molecular Oncology, EarlyView.
wiley   +1 more source